Morgan Stanley raised the firm’s price target on NOV Inc. (NOV) to $20 from $18 and keeps an Equal Weight rating on the shares. Beyond the Middle East disruption, the firm expects higher oil prices to be supportive of increased upstream capital spending, says the analyst, who notes that the firm’s 2027/2028 EBITDA estimates are now about 6% above consensus on average for the firm’s energy services and equipment coverage.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOV:
- NOV Inc. downgraded to Sector Perform from Outperform at RBC Capital
- NOV Inc. price target raised to $22 from $21 at Susquehanna
- NOV Inc. to double capacity of Acu subsea flexible pipe manufacturing facility
- NOV adds seasoned industrial leader to its board
- NOV Inc. price target raised to $20 from $17 at Goldman Sachs